$2.36
-0.02-0.84%
Last update: Nov 10, 7:16 PM
NRX Pharmaceuticals Inc
NRXPNASDAQ
The average analyst price target for NRX Pharmaceuticals is $29.71, 1164.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $10 to $51. The latest change came on Nov 2, 2026, when Ascendiant Capital raised its price target on NRX Pharmaceuticals from $50 to $51 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
